Posts Tagged ‘melanocyte’

Melanocyte Course and Melanoma Meeting Reports: Reykjavik (Iceland) 21-26 June 2015

Thursday, August 27th, 2015
Students and teachers at the university

Students and teachers at the university

Final Report of the International Course

The international course From Melanocyte Development to Melanoma Therapies – Basic Science and Clinical Applications, occurred at the University of Iceland, in Reykjavik June 21-24, 2015. Major advances in basic research of melanoma have lead to novel treatment options that are making a difference for melanoma patients. However, multiple challenges lie ahead and further progress is necessary, particularly with respect to resistance to the novel therapies. Our course taught the basic biology and development of the melanocyte how these cells are transformed into melanoma, and how the disease is diagnosed and treated. A particular emphasis was on novel therapeutic options and the resistance that arises against the new drugs. Another main issue was to bring together the future leaders in the field with an MD and/or a PhD background.
The course had seven main themes: (i) Introduction to melanocytes and melanoma. (ii) Clinical diagnosis and prognosis, (iii) Histology and histopathology, (iv) Molecular and (epi)genetic techniques, (v) Experimental animals, (vi) High throughput data analysis, and (vii) Therapy, current clinical practice and preclinical advances.
The objective of this course was clearly defined. In recent years, research into melanocytes and melanoma has lead to giant steps in treatment of melanoma patients. The goal of this course was to teach students about the basic biology of melanoma with a particular emphasis on therapeutic options. The students learnt about this rapidly advancing field, and since the students came from both basic and clinical sciences, they learnt from each other in order to advance melanoma diagnosis and therapy in the future.
Hosting the course in Iceland allowed us to bring together European and American students and taught them about the latest advances in the field. This three day course was followed by a three day meeting “Melanoma: from basic science to clinical applications“ (http://www.melanoma2015.is) where leaders in the field will talk about their latest results. This allowed us to include some of the most important players in the field as teachers in the course. This meeting was highly appreciated by the 120 participants.
The success of the course relied on the active contribution of participants who were proactive and participated in all of the events organized including: (i) presentation of their own scientific project with a 8 minutes oral presentation, and (ii) participation in the “career development” workshop during the last day of the course.
The course will have a broad view of the melanocyte lineage, including the establishment of the lineage during embryonic development and the renewal of melanocytes from normal melanocyte stem cells. The similarities between the cellular and molecular mechanisms that occur during development, renewal and melanomagenesis will be explored for further clinical advancement. Lectures on epigenetics, genomics and clinical aspects of melanoma will bring a broader view of the field for the PhD students, postdoctoral fellows and junior scientists attending the course.
Lunches and Dinners were attended by both teachers and students giving opportunities for further discussions and this time was used as round tables.
In figures, 28 students (3 Master students, 17 PhD/MD-PhD students, 4 Post-docs, and 4 MD) with 17 females and 11 males participated to this course. We got a feed-back from the survey of the course from 23 students. These students came from Iceland (8), France (7), North America (4), Sweden (2) and also from UK, Belgium, Luxembourg, Germany, Holland and Hungary. Overall, they were either satisfied or highly satisfied by this course.
In conclusion, it was a real pleasure for the organizers, the teachers and the students to participate to this course. We are ready to organize a similar course in 2017. The location is still unclear, but an option is taken in Israel.
The organizers : Lionel LARUE, Eirikur STEINGRIMSSON, Thorunn RAFNAR and Colin GODING
Students and teachers at the blue Lagoon

Students and teachers at the blue Lagoon

Final Report of the Melanoma Meeting

The international meeting Melanoma: From Basic Science to Clinical Applications, was held in the Harpa Conference Center and Concert Hall, Reykjavik, Iceland, June 24-26, 2015. Major advances in basic research of melanoma have lead to novel treatment options that are making a difference for melanoma patients. However, multiple challenges lie ahead and further progress is necessary, particularly with respect to resistance to the novel therapies. The meeting covered topics ranging from the basic biology and development of the melanocyte to how these cells are transformed into melanoma, and how the disease is diagnosed and treated. A particular emphasis was to bridge the basic and clinical sciences of melanoma and to span the Atlantic divide by bringing American and European melanoma scientists together. Another main issue was to bring together the future leaders in the field.
The meeting was divided into five sessions: (i-ii) Melanocyte and melanoma development 1a and 1b. (ii) Gene regulation in melanocytes and melanoma, (iii) Cell biology to Pathology, (iv) Pathology to Genomics, (v) Clinical advances. One of the lunch breaks was conducted as a separate session termed Luncheon clinical Update and Current Needs.
The meeting was very successful. First, the speakers gave outstanding talks and ample time was allowed for questions and discussions. Second, the frequent coffee breaks and social events allowed further discussions and interactions. And third, the social events, including the Welcome reception, Conference dinner and the trip to the Blue Lagoon further enhanced interactions and discussions. We have received nothing but praise and adulation for the organization of the meeting, its scientific content, the location in Iceland and the friendly and interactive atmosphere we succeeded in creating.
The meeting was attended by a total of 120 people from 17 different countries. The speakers were from both Europe and the US, 14 females and 22 males. They were both established leading investigators and younger speakers selected from abstracts.
Support for the meeting was obtained from various institutions and companies, including Institut Curie, University of Iceland, ESPCR, PASPCR, The French Embassy in Iceland, the Icelandic Cancer Society, University of Colorado Cancer Center, Provectus, Incyte, Amgen, Metabolon, Lytix biopharma, Viralytics and Bristol Myers Squibb. We thank all these organizations for their generous contributions.
The organizers: Lionel LARUE, Eirikur STEINGRIMSSON, Thorunn RAFNAR, Robert ANDTBACKA, Rene GONZALEZ, Karl LEWIS, Caroline ROBERT and Ze’ev RONAI